Diabetes patients can be a target for chronic kidney disease but can also take aim back: This is the message from AstraZeneca’s new Farxiga TV ad, which is pushing the drug’s new CKD label. There is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback